RHINOCYTE
RhinoCyte engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company's technology is used to treat conditions, such as Parkinson's disease, Multiple Sclerosis, Alzheimer's disease, and spinal cord injuries. RhinoCyte, Inc. was founded in 2005 and is based in Louisville, Kentucky.
RHINOCYTE
Industry:
Biotechnology Life Science Medical
Founded:
2005-01-01
Address:
Louisville, Kentucky, United States
Country:
United States
Website Url:
http://www.rhinocyte.com
Total Employee:
1+
Status:
Active
Contact:
(502)410-0399
Email Addresses:
[email protected]
Total Funding:
4.7 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright WordPress 4.0
Similar Organizations
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Queen City Angels
Queen City Angels investment in Series A - RhinoCyte
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Series A - RhinoCyte
Kentucky Seed Capital Fund
Kentucky Seed Capital Fund investment in Series A - RhinoCyte
Official Site Inspections
http://www.rhinocyte.com
- Host name: 172.67.153.75
- IP address: 172.67.153.75
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RhinoCyte"
RhinoCyte - Crunchbase Company Profile & Funding
RhinoCyte engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases. Its …See details»
RhinoCyte Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for RhinoCyte. Use the PitchBook Platform to explore the full profile.See details»
RhinoCyte - VentureRadar
Website: http://www.rhinocyte.com. RhinoCyte is an emerging biopharmaceutical company focused on developing innovative treatments using stem cells taken from the nose lining of …See details»
RhinoCyte, Inc. | Louisville, KY, USA Startup - Gust
RhinoCyteâ„¢, Inc. is a biotechnology company founded in 2005. RhinoCyte will be a leader in the advancement of cell based therapies by providing innovative auto. RhinoCyte’s lead product is …See details»
RhinoCyte - Products, Competitors, Financials, Employees, …
RhinoCyte is a biotechnology company that has developed a method of isolating adult stem cells located in the olfactory regions of the mucosal lining of the human nasal passageway, which …See details»
Fred J. Roisen: Positions, Relations and Network - MarketScreener
Roisen is the founder of RhinoCyte, Inc. which was founded in 2005. He held the title of President & Chief Executive Officer from 2009 to 2013. Currently, he is a Professor at the University of …See details»
RhinoCyte - Funding, Financials, Valuation & Investors - Crunchbase
RhinoCyte develops and commercializes diagnostic tools and therapies for the stem cell treatment of neurological diseases.See details»
RhinoCyte - Regenerative Medicine Now
RhinoCyte engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases.See details»
RhinoCyte - Contacts, Employees, Board Members, Advisors
RhinoCyte develops and commercializes diagnostic tools and therapies for the stem cell treatment of neurological diseases.See details»
RhinoCyte - Company Presentation - YouTube
Presented by: Teresa Leezer, PresidentRhinoCyteâ„¢, Inc. is a biopharmaceutical company focused on developing an innovative stem cell platform for neurodegener...See details»
Orphanet: RhinoCyte, Inc.
RhinoCyte, Inc. RhinoCyte, Inc. 201 E. Jefferson Street. LOUISVILLE KY 40202-1246 . UNITED STATES. Institution's website EUGT Number: 238098 Contacts. Professionals: RHINOCYTE, …See details»
RhinoCyte Asset Profile | Preqin
Based in the US, RhinoCyte Inc. develops a breakthrough technology engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of …See details»
RhinoCyte - Company Presenation - YouTube
Presented by: Teresa Leezer, CEORhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will ...See details»
Study Shows Olfactory Stem Cells Outperform Skin Stem Cells in ...
Feb 21, 2012 · RhinoCyteâ„¢ currently has three patents for olfactory stem cell treatments approved in the United States, Australia and Israel, with others pending worldwide. Learn …See details»
Fred Roisen - Owner @ RhinoCyte - Crunchbase Person Profile
Fred Roisen is the Owner at RhinoCyte. There is no recent news or activity for this profile.See details»
Orphanet: RHINOCYTE, INC.
RhinoCyte, Inc. RhinoCyte, Inc. 201 E. Jefferson Street LOUISVILLE KY 40202-1246 UNITED STATES Institution's website More information. Additional information. Activities of this person. …See details»
Adult Human Olfactory Epithelial-Derived Progenitors: A Potential ...
Jun 1, 2012 · C.L. and F.R. helped found RhinoCyte, Inc., in 2005 and have a financial interest in the company. RhinoCyte provides the University of Louisville with a grant for F.R.'s research.See details»
Research programme: olfactory epithelium stem cell therapy
RhinoCyte Inc. was developing an autologous adult olfactory epithelium-derived stem cell therapy for the treatment of spinal cord injury (SCI) andSee details»
RhinoCyte - Tech Stack, Apps, Patents & Trademarks - Crunchbase
RhinoCyte develops and commercializes diagnostic tools and therapies for the stem cell treatment of neurological diseases.See details»
Olfactory Neuroepithelial Neural Progenitor Cells from Subjects …
Research into the pathophysiology of bipolar disorder (BD) is limited by the inability to examine brain cellular processes in subjects with the illness. Endoscopic biopsy was performed in …See details»